Screener
PTC Therapeutics PTCT Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Tangible asset impairment and losses on transactions, net | 927 | 77 |
| Unrealized loss on ClearPoint Equity Investments | — | 3,122 |
| Unrealized gain on marketable securities - equity investments | (1,214) | (774) |
| Deferred income taxes | (10) | 2 |
| Amortization of discounts on investments, net | (4,114) | (2,313) |
| Amortization of debt issuance costs | 305 | 299 |
| Share-based compensation expense | 23,421 | 18,060 |
| Unrealized foreign currency transaction losses, net | (887) | 2,251 |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's deferred tax assets?
- PTC Therapeutics (PTCT) reported deferred tax assets of -$10K in Q1 2026.
- How has PTC Therapeutics's deferred tax assets changed year-over-year?
- PTC Therapeutics's deferred tax assets decreased by 600.0% year-over-year, from $2K to -$10K.
- What is the long-term trend for PTC Therapeutics's deferred tax assets?
- Over 4 years (2020 to 2024), PTC Therapeutics's deferred tax assets has grown at a -20.0% compound annual growth rate (CAGR), from $136.74M to -$55.91M.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.
Ask your AI about PTC Therapeutics's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude